ArticleSignal transduction and targeted therapy2019

Deletion of the RNA-editing enzyme ADAR1A: new strategy to potentiate responses to PD-1 immune checkpoint blockade.

Manni Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.